From research to licensure and beyond: clinical development of MenB-FHbp, a broadly protective meningococcal B vaccine

Abstract excerpt

INTRODUCTION: Given the characteristics of meningococcal carriage and transmission and the sudden, often severe onset and long-term consequences of disease, vaccination can most effectively provide large-scale control of invasive disease. Six serogroups (A, B, C, W, X, and Y) cause nearly all meningococcal disease globally. Capsular polysaccharide conjugate vaccines can prevent serogroups A, C, W, and Y disease....

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Bacterial Infections and Vaccines
• Share to Pneumonia and Respiratory Infections
• Share to Respiratory viral infections research